Design and Rationale of the RE‐DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting

Antithrombotic management of patients with atrial fibrillation (AF) undergoing coronary stenting is complicated by the need for anticoagulant therapy for stroke prevention and dual antiplatelet therapy for prevention of stent thrombosis and coronary events. Triple antithrombotic therapy, typically c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cannon, Christopher P., Gropper, Savion, Bhatt, Deepak L., Ellis, Stephen G., Kimura, Takeshi, Lip, Gregory Y.H., Steg, Ph. Gabriel, ten Berg, Jurriën M., Manassie, Jenny, Kreuzer, Jörg, Blatchford, Jon, Massaro, Joseph M., Brueckmann, Martina, Ferreiros Ripoll, Ernesto, Oldgren, Jonas, Hohnloser, Stefan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2016
Materias:
Trial Designs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108471/
https://www.ncbi.nlm.nih.gov/pubmed/27565018
http://dx.doi.org/10.1002/clc.22572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108471/
https://www.ncbi.nlm.nih.gov/pubmed/27565018
http://dx.doi.org/10.1002/clc.22572

Ejemplares similares